Pharma Journalist -

Swedish Orphan Biovitrum AB confirmed FDA's acceptance of the investigational new drug application for the drug candidate SOBI003 along with granting Fast track status to it. SOBI003 is…
Read More...

Evofem Biosciences committed to the development and commercialization of women's healthcare products asserted the enrollment of its first patient in  Phase 2b/3 clinical trial…
Read More...

ProMIS Neurosciences committed to the discovery and development of precision treatments for neurodegenerative diseases, announced further results of its previously announced and ongoing…
Read More...

Biomarck Pharmaceuticals affirmed initiation of Phase 2 Clinical study in advanced NSCLC.  The study is meant to compare  standard of Care Therapy alone to SOC plus BIO-11006. BIO-11006…
Read More...

U.S FDA grants clearance for QIAGEN's ipsogen JAK2 RGQ PCR Kit for ascertaining myeloproliferative neoplasms (MPNs), which are a group of cancers in which immature blood cells in the…
Read More...

Surefire Medical affirmed the appointment of Mary T. Szela as its CEO, President and a member of the company's Board Of Directors. James Chomas PhD precedes Szela who served as…
Read More...

JSR life sciences of the JSR corporation confirmed the appointment of Dr. Nalini Murdter as the President and Chief Executive Officer of MBL International with effect immediately.…
Read More...

Puma Biotechnology asserted that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has conveyed a negative trend vote after discussions…
Read More...

Cerus Corporation asserted successful achievement of primary efficacy and safety endpoints in the Company's Phase 3 transfusion study of Chronic anaemia assessing INTERCEPT-treated Red…
Read More...

One of the leading pharmaceutical companies in the Middle East and North Africa region, Tabuk Pharmaceuticals enters into licensing and supply agreement with red otc development GmbH on…
Read More...